Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...
Fintel reports that on March 12, 2025, BMO Capital initiated coverage of Dyne Therapeutics (NasdaqGS:DYN) with a Outperform ...
Stock market corrections of 10% hurt. But research shows that they often don't portend worse things ahead for stocks.
In a report released today, Kevin O’Halloran from BMO Capital maintained a Buy rating on Hochschild Mining (HOC – Research Report), with a ...
The revised estimates put Wall Street's average year-end target for the S&P 500 at 6,607, implying an advance of more than 17% from Friday's close of 5,638.94, according to a recent survey of Wall ...
BMO Capital analyst Kostas Biliouris initiated coverage of Dyne Therapeutics (DYN) with an Outperform rating and $50 price target The firm ...
The Federal Reserve is still expected to cut interest rates this year — but not until the fall — as policymakers weigh the fallout from President Trump’s tariffs on trade ...
The Federal Reserve is likely to keep interest rates steady through the first two quarters of the year before considering the first rate reductions of the year starting in September, Bloomberg reports ...
Canadian Pacific Kansas City Limited (TSX: CP) (NYSE: CP) ("CPKC") announced that its wholly-owned subsidiary, Canadian ...
ECN Capital Corp. (TSX: ECN) ("ECN Capital” or the "Company”) today announced that it has entered into an agreement with a syndicate of underwriters (the "Underwriters”) led by CIBC Capital Markets, ...
Duke Energy (NYSE:DUK – Free Report) had its price target boosted by BMO Capital Markets from $123.00 to $128.00 in a report published on Tuesday,Benzinga reports.They currently have an ...
Fintel reports that on March 10, 2025, BMO Capital upgraded their outlook for Samsara (NYSE:IOT) from Market Perform to Outperform. As of March 4, 2025, the average one-year price target for ...